White House Denies Trump Using Obesity Drug in Compassionate Use Program

Chronological Source Flow
Back

AI Fusion Summary

The White House has aggressively denied reports suggesting President Trump received exclusive access to an unapproved obesity drug through a compassionate use program. This follows a STAT News report stating that the FDA and Eli Lilly granted a 79-year-old man access to the weight loss medication after a request was submitted in April. The White House criticized the report that questioned whether the specific application for the drug was intended for the President.
Community Comments
Loading updates...
0